Compositions and methods for treating or preventing inflammatory diseases
AssigneeAngiotech Pharmaceuticals, Inc.
InventorWilliam L. Hunter
Life of this patent
Estimating the term…
Abstract
Methods and compositions for treating or preventing inflammatory diseases such as psoriasis or multiple sclerosis are provided, comprising the step of delivering to the site of inflammation an anti-microtubule agent, or analogue or derivative thereof.
Claims45
A method for treating or preventing multiple sclerosis, comprising administering to a patient a therapeutically effective amount of an anti-microtubule agent such that said multiple sclerosis is treated or prevented.
A method for treating or preventing psoriasis, comprising administering to a patient a therapeutically effective amount of an anti-microtubule agent, such that said psoriasis is treated or prevented.
A method for treating or preventing arthritis, comprising administering to a patient a therapeutically effective amount of an anti-microtubule agent, such that said arthritis is treated or prevented, with the proviso that said anti-microtubule agent is not paclitaxel, or an analogue or derivative thereof.
A method for treating stenosis, comprising administering to a patient a therapeutically effective amount of an anti-microtubule agent, such that said stenosis is treated or prevented, with the proviso that said anti-microtubule agent is not paclitaxel, or an analogue or derivative thereof.
A method for treating graft rejection, comprising administering to a patient an anti-microtubule agent.
A method for treating or preventing surgical adhesions, comprising administering to a patient a therapeutically effective amount of an anti-microtubule agent, such that said surgical adhesion is treated or prevented.
A method for treating inflammatory bowel disease, comprising administering to a patient a therapeutically effective amount of an anti-microtubule agent, such that said inflammatory bowel disease is treated or prevented.
A method for treating or preventing chronic inflammatory lung disease, comprising administering to a patient a therapeutically effective amount of an anti-microtubule agent, such that said nasal polyps are treated or prevented.
A method for treating periodontal disease, comprising administering to a patient a therapeutically effective amount of an anti-microtubule agent, such that said periodontal disease is treated or prevented.
A method for treating polycystic kidney disease, comprising administering to a patient a therapeutically effective amount of an anti-microtubule agent, such that said polycystic kidney disease is treated or prevented.
A method for treating systemic lupus erythematosus, comprising administering to a patient a therapeutically effective amount of an anti-microtubule agent, such that said systemic lupus erythematosus is treated or prevented.
Dependencies are inferred from the claim text.